Valuation: OrganiGram

Market Cap 206M 145M 127M 117M 109M 13.68B 209M 1.4B 545M 6.75B 544M 532M 23.53B P/E 2026 *
11.2x
P/E 2027 * 36.5x
Enterprise Value 206M 145M 127M 117M 109M 13.68B 209M 1.4B 545M 6.75B 544M 532M 23.53B EV / Sales 2026 *
0.61x
EV / Sales 2027 * 0.47x
Free-Float
69.76%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 2026-01-14
Director of Finance/CFO - 2024-01-07
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 65 2018-03-28
Director/Board Member 56 2018-12-16
Director/Board Member 70 2018-12-16
Change 5-day change 1-year change 3-year change Capi.($)
-3.89%+9.83% - - 145M
+6.95%+5.82%+81.82%+234.00% 214M
+3.53%+10.00%+24.82%+95.56% 118M
+8.51%+10.87%+52.24%-17.74% 95.4M
+3.11%+12.36%+51.10%+3.00% 95.76M
+4.14%+6.19%-35.80%-46.90% 57.84M
Average +3.72%+1.89%+34.84%+53.58% 116.18M
Weighted average by Cap. +3.71%+1.62%+48.59%+98.44%

Financials

2026 *2027 *
Net sales 340M 239M 209M 193M 180M 22.61B 346M 2.32B 900M 11.16B 898M 878M 38.87B 441M 310M 272M 251M 234M 29.35B 449M 3.01B 1.17B 14.48B 1.17B 1.14B 50.46B
Net income 18.88M 13.29M 11.63M 10.74M 10.02M 1.26B 19.21M 129M 50.02M 620M 49.94M 48.82M 2.16B 6.53M 4.6M 4.02M 3.72M 3.47M 435M 6.65M 44.57M 17.3M 215M 17.28M 16.89M 747M
Net Debt - -
Logo OrganiGram
Organigram Global Inc. is focused on producing cannabis for adult recreational consumers, as well as developing international business partnerships. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. It operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. It operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-